Répertoire du corps professoral

Évaluation de l'impact des modifications apportées à la vaccination contre la coqueluche au Québec - Phase 3
Organisme(s) subventionnaire(s): Ministère de la Santé et des Services sociaux
Type de financement: Subvention
Établissement tête: Université Laval
Du 12 août 2024 au 31 mars 2025

Does a reduced-dose RotaTeq (RV5) vaccine schedule translate into a higher incidence of rotavirus infections compared to approved RV5 schedules?
Programme: Réseau canadien de recherche sur l’immunisation
Organisme(s) subventionnaire(s): Instituts de recherche en santé du Canada
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 juin 2023 au 31 mars 2025

Enquête cas témoins sur l'efficacité des vaccins contre les infections invasives à pneumocoques
Programme: Subvention de recherche
Organisme(s) subventionnaire(s): Ministère de la Santé et des Services sociaux
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 avril 2022 au 31 mars 2027

Évaluation de l'impact des modifications apportées à la vaccination contre la coqueluche au Québec
Organisme(s) subventionnaire(s): Ministère de la Santé et des Services sociaux
Type de financement: Subvention
Établissement tête: Université Laval
Du 27 juillet 2020 au 30 juin 2025

Immuno VHB 2/3 doses nourissons
Organisme(s) subventionnaire(s): Ministère de la Santé et des Services sociaux
Type de financement: Subvention
Établissement tête: Université Laval
Du 20 décembre 2017 au 31 mars 2026

Financements des 2 dernières années

Koffi Barnabé Kegbevi, Maîtrise en santé publique - avec mémoire

Publications des 5 dernières années

Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: impact of variant replacement and waning protection during 10-month follow-up 2024/11/13. Sara Carazo, Danuta M Skowronski, Nicholas M Brousseau, Charles-Antoine Guay, Chantal Sauvageau, Étienne Racine, Denis Talbot, Iulia G Ionescu, Judith Fafard, Rodica Gilca, Jonathan Phimmasone, Philippe De Wals, Gaston De Serres. DOI 10.1101/2024.11.13.24317190

Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants 2024/03/24. Gebremedhin Gebretekle, Man Wah Yeung, Ximenes R, Alexandra Cernat, Alison E. Simmons, April Killikelly, Winnie Siu, Ellen Rafferty, Nicholas Brousseau, Matthew C. Tunis, Ashleigh Tuite. DOI 10.1101/2024.03.21.24304675

Respiratory syncytial virus vaccination strategies for older Canadian adults: a cost-utility analysis 2024/03/22. Ashleigh Tuite, Alison E. Simmons, Monica Rudd, Alexandra Cernat, Gebremedhin Gebretekle, Man Wah Yeung, April Killikelly, Winnie Siu, Sarah Buchan, Nicholas Brousseau, Matthew C. Tunis. DOI 10.1101/2024.03.20.24304630

Burden of Disease of Respiratory Syncytial Virus in Older Adults and Adults Considered at High Risk of Severe Infection 2024/03/19. Elissa Abrams, Pamela Doyon-Plourde, Phaedra Davis, Liza Lee, Abbas Rahal, Nicholas Brousseau, Winnie Siu, April Killikelly. DOI 10.1101/2024.03.18.24304476

Vaccination during pregnancy and modulation of IgG response to pertussis vaccines in infants: The impact of different vaccine formulations Vaccine, 2024. Brousseau, Nicholas, Angers-Goulet, Marie-Elen, Bastien, Robin, Ye, Lingyun, Sadarangani, Manish, Halperin, Scott A. DOI 10.1016/j.vaccine.2024.03.015

The safety of seasonal influenza vaccination among adults prescribed immune checkpoint inhibitors: A self-controlled case series study using administrative data Vaccine, 2024. Grima, Alicia A, Kwong, Jeffrey C, Richard, Lucie, Reid, Jennifer, Raphael, Jacques, Basta, Nicole E, Carignan, Alex, Top, Karina A, Brousseau, Nicholas, Blanchette, Phillip S, Sundaram, Maria E, Canadian Immunization Research Network (CIRN) Investigators. DOI 10.1016/j.vaccine.2024.01.023

Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024. Brousseau, Nicholas, Carazo, Sara, Febriani, Yossi, Padet, Lauriane, Hegg-Deloye, Sandrine, Cadieux, Geneviève, Bergeron, Geneviève, Fafard, Judith, Charest, Hugues, Lambert, Gilles, Talbot, Denis, Longtin, Jean, Dumont-Blais, Alexandre, Bastien, Steve, Dalpé, Virginie, Minot, Pierre-Henri, De Serres, Gaston, Skowronski, Danuta M. DOI 10.1093/cid/ciad584

Neighborhood-level vaccine impact on COVID-19 infection and hospital admission in Quebec, Canada, during the Delta and early Omicron periods Vaccine, 2024. Lo, Ernest, Brousseau, Nicholas, Defay, Fannie, Fortin, Élise, Kiely, Marilou. DOI 10.1016/j.vaccine.2023.12.043

Burden of disease of respiratory syncytial virus in infants, young children and pregnant women and people Canada communicable disease report = Releve des maladies transmissibles au Canada, 2024. Abrams, Elissa M, Doyon-Plourde, Pamela, Davis, Phaedra, Brousseau, Nicholas, Irwin, Andrea, Siu, Winnie, Killikelly, April. DOI 10.14745/ccdr.v50i12a01

Antenatal tetanus, diphtheria, and acellular pertussis (Tdap) immunization and risk of serogroup 19 IPD in children: An indirect cohort study Human vaccines & immunotherapeutics, 2024. Thibault, Melina, Deceuninck, Geneviève, Quach, Caroline, Brousseau, Nicholas. DOI 10.1080/21645515.2024.2305522

Large-scale validation of a plasmonic sensor for SARS-CoV-2 pseudo-neutralization with a cohort of food and retail workers 2023/12/15. Julien Coutu, Pierre Ricard, Abdelhadi Djaïleb, Etienne Lavallée, Henintsoa Rabazanaha, Matthew Stuible, Yves Durocher, Caroline Gilbert, Nicholas Brousseau, Kim Santerre, Mathieu Thériault, Sylvie Trottier, Denis Boudreau, Marc-André Langlois, Joelle Pelletier, Mariana Baz, Jean-Francois Masson. DOI 10.26434/chemrxiv-2023-3cwjs

Live virus neutralizing antibodies against pre and post Omicron strains in food and retail workers in Québec, Canada 2023/09/03. Henintsoa Rabezanahary, Caroline Gilbert, Kim Santerre, Martina Scarrone, Megan Gilbert, Mathieu Thériault, Nicholas Brousseau, Jean-François Masson, Joelle N. Pelletier, Denis Boudreau, Sylvie Trottier, Mariana Baz. DOI 10.1101/2023.09.03.23294976

Cohort Profile: Prospective Cohort to Study the COVID-19 Immune Response in Retail Workers in Québec, Canada (CISACOV) 2023/08/21. Kim Santerre, Mathieu Thériault, Nicholas Brousseau, Samuel Rochette, Joelle Pelletier, Caroline Gilbert, Jean-Francois Masson, Mariana Baz, Denis Boudreau, Sylvie Trottier. DOI 10.1101/2023.08.18.23294172

Tdap vaccine in pregnancy and immunogenicity of pertussis and pneumococcal vaccines in children: What is the impact of different immunization schedules Vaccine, 2023. Febriani, Yossi, Mansour, Thowiba, Sadarangani, Manish, Ulanova, Marina, Amaral, Kyle, Halperin, Scott A, De Serres, Gaston, Racine, Étienne, Brousseau, Nicholas. DOI 10.1016/j.vaccine.2023.09.063

Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study The Lancet. Infectious diseases, 2023. Carazo, Sara, Skowronski, Danuta M, Brisson, Marc, Barkati, Sapha, Sauvageau, Chantal, Brousseau, Nicholas, Gilca, Rodica, Fafard, Judith, Talbot, Denis, Ouakki, Manale, Gilca, Vladimir, Carignan, Alex, Deceuninck, Geneviève, De Wals, Philippe, De Serres, Gaston. DOI 10.1016/S1473-3099(22)00578-3

Increase of invasive pneumococcal disease in children temporally associated with RSV outbreak in Quebec: a time-series analysis Lancet regional health. Americas, 2023. Ouldali, Naïm, Deceuninck, Geneviève, Lefebvre, Brigitte, Gilca, Rodica, Quach, Caroline, Brousseau, Nicholas, Tapiero, Bruce, De Wals, Philippe. DOI 10.1016/j.lana.2023.100448

Effectiveness of thirteen-valent pneumococcal conjugate vaccine to prevent serotype 3 invasive pneumococcal disease in Quebec in children, Canada Vaccine, 2023. Deceuninck, Geneviève, Brousseau, Nicholas, Lefebvre, Brigitte, Quach, Caroline, Tapiero, Bruce, Bui, Yen-Giang, Desjardins, Michaël, De Wals, Philippe. DOI 10.1016/j.vaccine.2023.07.049

Effectiveness of previous infection-induced and vaccine-induced protection against hospitalisation due to omicron BA subvariants in older adults: a test-negative, case-control study in Quebec, Canada The lancet. Healthy longevity, 2023. Carazo, Sara, Skowronski, Danuta M, Brisson, Marc, Sauvageau, Chantal, Brousseau, Nicholas, Fafard, Judith, Gilca, Rodica, Talbot, Denis, Ouakki, Manale, Febriani, Yossi, Deceuninck, Geneviève, De Wals, Philippe, De Serres, Gaston. DOI 10.1016/S2666-7568(23)00099-5

Clonal diversity of Streptococcus pneumoniae serotype 19A collected from children < 5 years old in Québec, Canada, 2016-2021 Vaccine, 2023. Golden, Alyssa R, Lefebvre, Brigitte, Deceuninck, Geneviève, Brousseau, Nicholas, De Wals, Philippe, Quach, Caroline, Demczuk, Walter H B, Martin, Irene. DOI 10.1016/j.vaccine.2023.09.042

Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022. Skowronski, Danuta M, Febriani, Yossi, Ouakki, Manale, Setayeshgar, Solmaz, El Adam, Shiraz, Zou, Macy, Talbot, Denis, Prystajecky, Natalie, Tyson, John R, Gilca, Rodica, Brousseau, Nicholas, Deceuninck, Geneviève, Galanis, Eleni, Fjell, Chris D, Sbihi, Hind, Fortin, Elise, Barkati, Sapha, Sauvageau, Chantal, Naus, Monika, Patrick, David M, Henry, Bonnie, Hoang, Linda M N, De Wals, Philippe, Garenc, Christophe, Carignan, Alex, Drolet, Mélanie, Jassem, Agatha N, Sadarangani, Manish, Brisson, Marc, Krajden, Mel, De Serres, Gaston. DOI 10.1093/cid/ciac290

Summary of the National Advisory Committee on Immunization (NACI) Rapid Response: Updated interim guidance on Imvamune in the context of ongoing monkeypox outbreaks Canada communicable disease report = Releve des maladies transmissibles au Canada, 2022. Forbes, Nicole, Baclic, Olivier, Harrison, Robyn, Brousseau, Nicholas.

Summary of the National Advisory Committee on Immunization (NACI) Rapid Response-Interim guidance on the use of Imvamune in the context of monkeypox outbreaks in Canada Canada communicable disease report = Releve des maladies transmissibles au Canada, 2022. Killikelly, April, Brousseau, Nicholas. DOI 10.14745/ccdr.v48i78a09

Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses Cell host & microbe, 2022. Tauzin, Alexandra, Gong, Shang Yu, Beaudoin-Bussières, Guillaume, Vézina, Dani, Gasser, Romain, Nault, Lauriane, Marchitto, Lorie, Benlarbi, Mehdi, Chatterjee, Debashree, Nayrac, Manon, Laumaea, Annemarie, Prévost, Jérémie, Boutin, Marianne, Sannier, Gérémy, Nicolas, Alexandre, Bourassa, Catherine, Gendron-Lepage, Gabrielle, Medjahed, Halima, Goyette, Guillaume, Bo, Yuxia, Perreault, Josée, Gokool, Laurie, Morrisseau, Chantal, Arlotto, Pascale, Bazin, Renée, Dubé, Mathieu, De Serres, Gaston, Brousseau, Nicholas, Richard, Jonathan, Rovito, Roberta, Côté, Marceline, Tremblay, Cécile, Marchetti, Giulia C, Duerr, Ralf, Martel-Laferrière, Valérie, Kaufmann, Daniel E, Finzi, Andrés. DOI 10.1016/j.chom.2021.12.004

Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, Canada Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022. Carazo, Sara, Talbot, Denis, Boulianne, Nicole, Brisson, Marc, Gilca, Rodica, Deceuninck, Geneviève, Brousseau, Nicholas, Drolet, Mélanie, Ouakki, Manale, Sauvageau, Chantal, Barkati, Sapha, Fortin, Élise, Carignan, Alex, De Wals, Philippe, Skowronski, Danuta M, De Serres, Gaston. DOI 10.1093/cid/ciab739

Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada JAMA network open, 2022. Carazo, Sara, Skowronski, Danuta M, Brisson, Marc, Sauvageau, Chantal, Brousseau, Nicholas, Gilca, Rodica, Ouakki, Manale, Barkati, Sapha, Fafard, Judith, Talbot, Denis, Gilca, Vladimir, Deceuninck, Geneviève, Garenc, Christophe, Carignan, Alex, De Wals, Philippe, De Serres, Gaston. DOI 10.1001/jamanetworkopen.2022.36670

Do intentions lead to action? Results of a longitudinal study assessing determinants of Tdap vaccine uptake during pregnancy in Quebec, Canada BMC pregnancy and childbirth, 2022. Dubé, Eve, Trottier, Marie-Eve, Vivion, Maryline, Ouakki, Manale, Brousseau, Nicholas, Guay, Maryse, Laghdir, Zineb, Boucoiran, Isabelle, Tapiéro, Bruce, Quach, Caroline. DOI 10.1186/s12884-022-04809-6

Coverage for pertussis vaccination during pregnancy with 4 models of vaccine delivery: a quasiexperimental, multicentre observational study CMAJ open, 2022. Li, Yinan, Brousseau, Nicholas, Guay, Maryse, Dubé, Ève, Laghdir, Zineb, Boucoiran, Isabelle, Tapiéro, Bruce, Quach, Caroline. DOI 10.9778/cmajo.20210011

COVID-19 pandemic impact on childhood vaccination coverage in Quebec, Canada Human vaccines & immunotherapeutics, 2022. Kiely, Marilou, Mansour, Thowiba, Brousseau, Nicholas, Rafferty, Ellen, Paudel, Yuba Raj, Sadarangani, Manish, Svenson, Lawrence W, Robinson, Joan L, Gagneur, Arnaud, Driedger, S Michelle, MacDonald, Shannon E. DOI 10.1080/21645515.2021.2007707

SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2021. Brousseau, Nicholas, Morin, Laurianne, Ouakki, Manale, Savard, Patrice, Quach, Caroline, Longtin, Yves, Cheng, Matthew P, Carignan, Alex, Dufresne, Simon F, Leduc, Jean-Michel, Lavallée, Christian, Gauthier, Nicolas, Bestman-Smith, Julie, Arrieta, Maria-Jesus, Ishak, Magued, Lévesque, Simon, Martin, Philippe, De Serres, Gaston. DOI 10.1503/cmaj.202783

Vaccination during pregnancy: Canadian maternity care providers' opinions and practices Human vaccines & immunotherapeutics, 2020. Dube, Eve, Gagnon, Dominique, Kaminsky, Kyla, Green, Courtney R, Ouakki, Manale, Bettinger, Julie A, Brousseau, Nicholas, Castillo, Eliana, Crowcroft, Natasha S, Driedger, S Michelle, Greyson, Devon, Fell, Deshayne, Fisher, William, Gagneur, Arnaud, Guay, Maryse, Halperin, Donna, Halperin, Scott A, MacDonald, Shannon, Meyer, Samantha B, Waite, Nancy M, Wilson, Kumanan, Witteman, Holly O, Yudin, Mark, Cook, Jocelynn L. DOI 10.1080/21645515.2020.1735225

Participation in an action research project on vaccine services for children: relationship with vaccine delays Human vaccines & immunotherapeutics, 2020. Beauregard, Mariejka, Brousseau, Nicholas, Ouakki, Manale, Kiely, Marilou, Sauvageau, Chantal, Clément, Paule, Guay, Maryse. DOI 10.1080/21645515.2020.1748980

Impact of the adolescent pertussis booster dose on the incidence of pertussis in British Columbia and Quebec, Canada Vaccine, 2020. Brousseau, Nicholas, Skowronski, Danuta M, Bellemare, David, Amini, Rachid, Joffres, Yayuk, Clarke, Quinten, Quach, Caroline, Rallu, Fabien, Hoang, Linda, De Serres, Gaston. DOI 10.1016/j.vaccine.2019.10.063

Vaccination Against Influenza in Pregnancy: A Survey of Canadian Maternity Care Providers Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2019. Dube, Eve, Gagnon, Dominique, Kaminsky, Kyla, Green, Courtney R, Ouakki, Manale, Bettinger, Julie A, Brousseau, Nicholas, Castillo, Eliana, Crowcroft, Natasha S, Driedger, S Michelle, Greyson, Devon, Fell, Deshayne, Fisher, William, Gagneur, Arnaud, Guay, Maryse, Halperin, Donna, Halperin, Scott A, MacDonald, Shannon, Meyer, Samantha B, Waite, Nancy M, Wilson, Kumanan, Witteman, Holly O, Yudin, Mark, Cook, Jocelynn L, Canadian Immunization Network. DOI 10.1016/j.jogc.2018.09.007

Addressing HPV vaccine hesitancy with motivational interviewing technique HPV World: the newsletter on HPV, 2019. Nicholas Brousseau.

A public health enhanced surveillance system for a mass gathering event Canada communicable disease report = Releve des maladies transmissibles au Canada, 2019. Huot, C, Paradis, A, Hammond-Collins, K, Bélair, M A, Villeneuve, J, Brousseau, N, Goupil-Sormany, I, Riffon, J. DOI 10.14745/ccdr.v45i78a05